Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?

Although the changes in log PC20 levels did not reach statistical significance in both SCIT and control groups after an average of 30–35 months of treatment, it was significant in favor of the SCIT group when the groups were compared in terms of the change in log PC20 after treatment ( Figure 4 , p = 0.026). 3.1.

also in 111,027 other papers